113 related articles for article (PubMed ID: 8134308)
1. Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme.
Cardozo C; Orlowski M
Peptides; 1993; 14(6):1259-62. PubMed ID: 8134308
[TBL] [Abstract][Full Text] [Related]
2. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
[TBL] [Abstract][Full Text] [Related]
3. Endopeptidase 3.4.24.11 converts N-1-(R,S)carboxy-3-phenylpropyl-Ala-Ala-Phe-p-carboxyanilide into a potent inhibitor of angiotensin-converting enzyme.
Williams CH; Yamamoto T; Walsh DM; Allsop D
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):681-4. PubMed ID: 8379924
[TBL] [Abstract][Full Text] [Related]
4. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
[TBL] [Abstract][Full Text] [Related]
5. Effects of a metalloendopeptidase-24.15. Inhibitor on renal hemodynamics and function in rats.
Yang XP; Saitoh S; Scicli AG; Mascha E; Orlowski M; Carretero OA
Hypertension; 1994 Jan; 23(1 Suppl):I235-9. PubMed ID: 8282366
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive properties of inhibitors of endopeptidase 24.15.
Kest B; Orlowski M; Molineaux CJ; Bodnar RJ
Int J Neurosci; 1991; 56(1-4):141-9. PubMed ID: 1938129
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate.
Chappell MC; Welches WR; Brosnihan KB; Ferrario CM
Peptides; 1992; 13(5):943-6. PubMed ID: 1336190
[TBL] [Abstract][Full Text] [Related]
8. Endopeptidase 24.15 modulates bradykinin-induced contraction in guinea-pig trachea.
Da Silva A; Dhuy J; Waeldelé F; Bertrand C; Landry Y
Eur J Pharmacol; 1992 Feb; 212(1):97-9. PubMed ID: 1372868
[TBL] [Abstract][Full Text] [Related]
9. Endopeptidase 24.15 inhibition and opioid antinociception.
Kest B; Orlowski M; Bodnar RJ
Psychopharmacology (Berl); 1992; 106(3):408-16. PubMed ID: 1349191
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone.
Lasdun A; Reznik S; Molineaux CJ; Orlowski M
J Pharmacol Exp Ther; 1989 Nov; 251(2):439-47. PubMed ID: 2681686
[TBL] [Abstract][Full Text] [Related]
11. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats.
Genden EM; Molineaux CJ
Hypertension; 1991 Sep; 18(3):360-5. PubMed ID: 1889849
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15.
Shrimpton CN; Abbenante G; Lew RA; Smith I
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):351-6. PubMed ID: 10620512
[TBL] [Abstract][Full Text] [Related]
14. Endopeptidase-24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo.
Molineaux CJ; Lasdun A; Michaud C; Orlowski M
J Neurochem; 1988 Aug; 51(2):624-33. PubMed ID: 3292705
[TBL] [Abstract][Full Text] [Related]
15. A novel synthetic inhibitor of endopeptidase-24.15.
Ukai Y; Li Q; Ito S; Mita S
J Enzyme Inhib; 1996 Aug; 11(1):39-49. PubMed ID: 9204395
[TBL] [Abstract][Full Text] [Related]
16. Modulatory effect of endopeptidase inhibitors on bradykinin-induced contraction of rat uterus.
Schriefer JA; Molineaux CJ
J Pharmacol Exp Ther; 1993 Aug; 266(2):700-6. PubMed ID: 8394914
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of metalloendopeptidase EC 3.4.24.15 and EC 3.4.24.16 stabilized against proteolysis by the incorporation of beta-amino acids.
Steer D; Lew R; Perlmutter P; Smith AI; Aguilar MI
Biochemistry; 2002 Sep; 41(35):10819-26. PubMed ID: 12196021
[TBL] [Abstract][Full Text] [Related]
18. Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid.
Barelli H; Dive V; Yiotakis A; Vincent JP; Checler F
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):621-5. PubMed ID: 1332678
[TBL] [Abstract][Full Text] [Related]
19. Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8.
Acker GR; Molineaux C; Orlowski M
J Neurochem; 1987 Jan; 48(1):284-92. PubMed ID: 2878974
[TBL] [Abstract][Full Text] [Related]
20. An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins.
Molineaux CJ; Ayala JM
J Neurochem; 1990 Aug; 55(2):611-8. PubMed ID: 1973455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
